<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.15651.004</object-id><label>Table 1.</label><caption><p>Patient group metadata for the Bangladeshi cohort.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15651.004">http://dx.doi.org/10.7554/eLife.15651.004</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Clinical parameter*</th><th>Culture confirmed typhoid<sup>&#8224;</sup> (n&#160;=&#160;10)<sup>&#182;</sup></th><th>Suspected typhoid<sup>&#8225;</sup> (n&#160;=&#160;9)</th><th>Fever controls<sup>&#167;</sup> (n&#160;=&#160;10)</th></tr></thead><tbody><tr><td>Age (years)</td><td>23 (20&#8211;30)</td><td>22 (16&#8211;30)</td><td>46 (20&#8211;65)</td></tr><tr><td>Sex (male)</td><td>5</td><td>6</td><td>8</td></tr><tr><td>Fever duration (days)</td><td>7 (5&#8211;11)</td><td>10 (6&#8211;12)</td><td>5 (5&#8211;9)</td></tr><tr><td>Abdominal pain</td><td>5</td><td>5</td><td>5</td></tr><tr><td>Diarrhoea</td><td>5</td><td>3</td><td>2</td></tr><tr><td>Constipation</td><td>1</td><td>4</td><td>2</td></tr><tr><td>Vomiting</td><td>5</td><td>7</td><td>3</td></tr><tr><td>Cough</td><td>2</td><td>1</td><td>7</td></tr><tr><td>Rash</td><td>0</td><td>2</td><td>0</td></tr><tr><td>Dysuria</td><td>0</td><td>0</td><td>2</td></tr><tr><td>Headache</td><td>6</td><td>4</td><td>6</td></tr><tr><td>Seizure</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Drowsy</td><td>0</td><td>2</td><td>2</td></tr><tr><td>Bloody stool/ Melaena</td><td>1</td><td>0</td><td>1</td></tr><tr><td>Confusion/unconscious</td><td>0</td><td>1</td><td>0</td></tr><tr><td>Axillary temperature (<sup>o</sup>C)</td><td>38.6 (38.3&#8211;39.4)</td><td>38.9 (38.5&#8211;39.4)</td><td>38.6 (38.3&#8211;38.9)</td></tr><tr><td>Pulse (bpm)</td><td>108 (97&#8211;114)</td><td>100 (92&#8211;110)</td><td>105 (86&#8211;123)</td></tr><tr><td>Jaundice</td><td>0</td><td>1</td><td>1</td></tr><tr><td>Hepatomegaly</td><td>1</td><td>2</td><td>1</td></tr><tr><td>Splenomegaly</td><td>0</td><td>0</td><td>1</td></tr><tr><td>Hb</td><td>11.9 (10.4&#8211;12.9</td><td>12.0 (9.6&#8211;12.1)</td><td>12.6 (10.4&#8211;14.0)</td></tr><tr><td>WBC</td><td>6.6 (4.9&#8211;8.4)</td><td>7.0 (4.2&#8211;8.5)</td><td>14.4 (10.7&#8211;21.1)</td></tr><tr><td>Neutrophils (%)</td><td>79 (70&#8211;81)</td><td>70 (63&#8211;72)</td><td>80 (78&#8211;88)</td></tr><tr><td>Lymphocytes (%)</td><td>19 (15&#8211;26)</td><td>25 (24&#8211;33)</td><td>15 (8&#8211;18)</td></tr><tr><td>Monocytes (%)</td><td>2 (2&#8211;3)</td><td>2 (2&#8211;4)</td><td>2 (2&#8211;4)</td></tr><tr><td>Eosinophils (%)</td><td>1 (1&#8211;1)</td><td>1 (1&#8211;2)</td><td>1 (1&#8211;2)</td></tr><tr><td>Platelets</td><td>170 (160&#8211;232)</td><td>180 (160&#8211;265)</td><td>280 (180&#8211;320)</td></tr><tr><td>Urea</td><td>24.6 (21.4&#8211;28.0)</td><td>24.1 (22.1&#8211;29.5)</td><td>67.9 (21.4&#8211;81.2)</td></tr><tr><td>Creatinine</td><td>0.9 0.6&#8211;1.0)</td><td>0.9 (.7&#8211;1.0)</td><td>1.6 (0.8&#8211;2.4)</td></tr><tr><td>AST</td><td>101 (47&#8211;137)</td><td>51 (33&#8211;199)</td><td>32 (16&#8211;78)</td></tr><tr><td>ALT</td><td>93 (48&#8211;137)</td><td>36 (28&#8211;105)</td><td>31 (20&#8211;43)</td></tr><tr><td>Complications**</td><td>2</td><td>0</td><td>4</td></tr><tr><td>Died<sup>&#8224;&#8224;</sup></td><td>0</td><td>0</td><td>2</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>*Median and interquartile range (IQR) for each patient group given for quantitative parameters and number of patients with presence of symptom/characteristics for qualitative parameters.</p></fn><fn id="tblfn2"><p><sup>&#8224;</sup>Typhoid confirmed by a positive blood culture for <italic>S</italic>. Typhi.</p></fn><fn id="tblfn3"><p><sup>&#8225;</sup>Clinical suspected typhoid fever with a negative blood culture, final diagnoses included: Clinically suspected typhoid with blood PCR amplification positive for <italic>S</italic>. Typhi (3); clinical suspected typhoid (4); clinical suspected typhoid or leptospirosis (1); possible typhoid encephalopathy (1).</p></fn><fn id="tblfn4"><p><sup>&#167;</sup>Fever controls included: pneumonia (3), malaria (2), meningitis (2); sepsis (1), cellulitis (1), urinary tract infection (1).</p></fn><fn id="tblfn5"><p><sup>&#182;</sup>One sample removed from analysis due to discrepant metabolite profile.</p></fn><fn id="tblfn6"><p>**Complications were: gastrointestinal bleeding and severe anaemia requiring transfusion in the typhoid group; respiratory failure, hepatorenal failure, septic shock and cardiopulmonary arrest, coma and cardiopulmonary arrest, and an acute myocardial infarction in the fever controls.</p></fn><fn id="tblfn7"><p><sup>&#8224;&#8224;</sup>Deaths in this group were associated with sepsis and malaria.</p></fn></table-wrap-foot></table-wrap>